Warner Chilcott Hit With Suit Over IPO Prospectus
Drug maker Warner Chilcott Ltd. deliberately failed to disclose that it had pulled one of its top earning drugs from shelves amid a federal antitrust investigation just days before its initial...To view the full article, register now.
Already a subscriber? Click here to view full article